Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2020 Oct 1;27(1):68.e1–68.e9. doi: 10.1016/j.bbmt.2020.09.026

Table 3:

Multivariable Analysis of Disease-Free and Overall Survival

Variables Number Disease-Free Survival Overall Survival
HR 95% CI) P value HR (95%CI) P value
Main effect <0.001 <0.001
RIC-L/I-Risk vs MAC-L/I-Risk: 999/1539 1.19 (1.07–1.33) 0.0012 1.11 (0.99–1.25) 0.0611
RIC-High-Risk vs MAC-High-Risk: 728/1121 1.07 (0.96–1.19) 0.240 1.00 (0.90–1.12) 0.978
MAC-High-Risk vs MAC-L/I-Risk: 1121/1539 1.82 (1.65–2.00) <0.001 1.77 (1.61–1.96) <0.001
RIC-High-Risk vs RIC-L/I-Risk: 728/999 1.63 (1.45–1.83) <0.001 1.60 (1.42–1.80) <0.001
Donor 0.0041 <.0001
HLA identical Sibling 1309 1.00 1.00
Mismatched relative (≥7/8) / Other relatives (missing HLA) 314 0.96 (0.80–1.17) 0.70 0.98 (0.83–1.17) 0.85
Matched unrelated donor (8/8) 1754 0.96 (0.88–1.06) 0.44 0.99 (0.90–1.10) 0.91
Unrelated (≤7/8) and matching unknown 412 1.11 (0.97–1.27) 0.14 1.26 (1.09–1.45) 0.0014
Umbilical cord blood 598 1.20 (1.06–1.37) 0.0041 1.49 (1.32–1.69) <0.001
Karnofsky Score <.0001 <.0001
<90 1788 1.00 1.00
≥90 2530 0.79 (0.74–0.86) <0.001 0.76 (0.70–0.82) <0.001
Missing 69 0.97 (0.73–1.29) 0.83 1.08 (0.81–1.45) 0.59
HCT-CI <.0001 <.0001
0 930 1.00 1.00
1 628 1.08 (0.95–1.23) 0.25 1.09 (0.95–1.25) 0.20
2 604 1.07 (0.94–1.22) 0.28 1.14 (0.99–1.30) 0.065
≥3 2191 1.24 (1.13–1.37) <0.001 1.35 (1.22–1.50) <0.001
Missing 34 1.40 (0.87–2.23) 0.17 1.21 (0.80–1.83) 0.36
GVHD prophylaxis 0.0157
TCD/CD34 122 1.00 - -
Tac + MMF/MTX +/− others 3348 0.95 (0.76–1.20) 0.67 - -
CSA + MMF/MTX +/− others 602 1.15 (0.90–1.46) 0.26 - -
Post-cy + others 206 1.02 (0.76–1.38) 0.88 - -
Others/Missing 109 1.15 (0.84–1.57) 0.39 - -
ATG/Alemtuzumab 0.0011 0.0053
Yes 1172 1.00 1.00
No 3207 0.86 (0.79–0.94) <0.001 0.88 (0.80–0.96) 0.0049
Missing 8 0.36 (0.11–1.15) 0.085 0.30 (0.07–1.19) 0.086
Year of transplant 0.0204 0.0003
2013–2015 2179 1.00 1.00
2009–2012 2208 1.10 (1.01–1.18) 0.020 1.16 (1.07–1.26) <0.001

GVHD, graft-versus-host disease. IPS, idiopathic pulmonary syndrome. ARDS, acute respiratory distress syndrome.